Literature DB >> 10861505

Delays in diagnosis and melanoma prognosis (II): the role of doctors.

M A Richard1, J J Grob, M F Avril, M Delaunay, J Gouvernet, P Wolkenstein, P Souteyrand, B Dreno, J J Bonerandi, S Dalac, L Machet, J C Guillaume, J Chevrant-Breton, C Vilmer, F Aubin, B Guillot, M Beylot-Barry, C Lok, N Raison-Peyron, P Chemaly.   

Abstract

A prospective survey was conducted to assess physician responsibility in melanoma prognosis. Consecutive patients with primary melanoma were interviewed and examined using a standardized questionnaire. Main outcome measures were medical components of the delay before tumor resection and tumor thickness. Of 590 melanomas, 29.1% were coincidentally detected by physicians and their tumor depth was lower than in melanomas detected by patients (p < 0.001). Physician sensitivity for melanoma diagnosis was evaluated at 86%. Median time intervals to propose resection and to perform removal of melanoma were short: 0 (mean 103) and 7 (mean 68) days, respectively. Melanomas were managed in an inappropriate way in 14.2% of cases. Location on acral areas and absence of pigmentation were associated with longer medical delays and more frequent inappropriate medical attitudes. Melanomas located on hardly visible areas were less frequently detected by physicians than those on visible areas. Medical delays were shorter, doctor's attitude was more frequently appropriate, and melanoma thickness was lower (p < 0.001) when the patient visited a dermatologist (54.7%) than when he or she visited a general practitioner (33.4%). Our study shows that doctor responsibility accounts for only a small part of the total delay before melanoma removal. However, systematic total examination and better training of doctors, especially about unusual forms of melanoma, could still improve melanoma detection. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10861505     DOI: 10.1002/1097-0215(20000520)89:3<280::aid-ijc11>3.0.co;2-2

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  The interface of primary and oncology specialty care: from symptoms to diagnosis.

Authors:  Larissa Nekhlyudov; Steven Latosinsky
Journal:  J Natl Cancer Inst Monogr       Date:  2010

2.  Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin).

Authors:  Melody J Eide; Martin A Weinstock; Raymond G Dufresne; Suleka Neelagaru; Patricia Risica; Gary J Burkholder; David Upegui; Katharine A Phillips; Bruce K Armstrong; Leslie Robinson-Bostom
Journal:  J Invest Dermatol       Date:  2005-02       Impact factor: 8.551

3.  Novice identification of melanoma: not quite as straightforward as the ABCDs.

Authors:  R Benjamin Aldridge; Matteo Zanotto; Lucia Ballerini; Robert B Fisher; Jonathan L Rees
Journal:  Acta Derm Venereol       Date:  2011-03       Impact factor: 4.437

4.  Landmark Series on Disparities in Surgical Oncology: Melanoma.

Authors:  Elliot A Asare; Umang Swami; John H Stewart
Journal:  Ann Surg Oncol       Date:  2021-06-30       Impact factor: 5.344

5.  Melanoma screening: Informing public health policy with quantitative modelling.

Authors:  Stephen Gilmore
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

6.  Dermoscopy as a technique for the early identification of foot melanoma.

Authors:  Ivan R Bristow; Jonathan Bowling
Journal:  J Foot Ankle Res       Date:  2009-05-12       Impact factor: 2.303

7.  Acral lentiginous melanoma of the foot and ankle: A case series and review of the literature.

Authors:  Ivan R Bristow; Katharine Acland
Journal:  J Foot Ankle Res       Date:  2008-09-15       Impact factor: 2.303

8.  Proposal for an annual skin examination by a general practitioner for patients at high risk for melanoma: a French cohort study.

Authors:  Cédric Rat; Charlotte Grimault; Gaelle Quereux; Maelenn Dagorne; Aurélie Gaultier; Amir Khammari; Brigitte Dreno; Jean-Michel Nguyen
Journal:  BMJ Open       Date:  2015-07-29       Impact factor: 2.692

9.  A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world.

Authors:  Mary Jane Sneyd; Brian Cox
Journal:  BMC Cancer       Date:  2013-08-06       Impact factor: 4.430

10.  Delay in cutaneous melanoma diagnosis: Sequence analyses from suspicion to diagnosis in 211 patients.

Authors:  Marcus H S B Xavier; Ana P Drummond-Lage; Cyntia Baeta; Lorena Rocha; Alessandra M Almeida; Alberto J A Wainstein
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.